| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
732.95 |
146.59 |
879.54 |
4% |
10 |
742.95 |
148.59 |
891.54 |
16% |
25 |
767.95 |
153.59 |
921.54 |
|
НСР-7189/09.10.2015.; НСР-11148/08.12.2016 г.; НСР-15140/02.03.2018 |
17.03.2018 |
02.04.2018 |
Активен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
752.35 |
150.47 |
902.82 |
4% |
10 |
762.35 |
152.47 |
914.82 |
16% |
25 |
787.35 |
157.47 |
944.82 |
|
НСР-7189/09.10.2015.; НСР-11148/08.12.2016 г. |
24.12.2016 |
02.01.2017 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
187.43 |
37.49 |
224.92 |
4% |
7.5 |
194.93 |
38.99 |
233.92 |
16% |
25 |
219.93 |
43.99 |
263.92 |
|
НСР-7187/09.10.2015.; НСР-11146/08.12.2016; НСР-15138/02.03.2018 |
17.03.2018 |
02.04.2018 |
Активен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, -, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
190.18 |
38.04 |
228.22 |
4% |
7.61 |
197.79 |
39.56 |
237.35 |
16% |
25 |
222.79 |
44.56 |
267.35 |
|
НСР-7187/09.10.2015.; НСР-11146/08.12.2016 |
24.12.2016 |
02.01.2017 |
Неактивен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
759.94 |
151.99 |
911.93 |
4% |
10 |
769.94 |
153.99 |
923.93 |
16% |
25 |
794.94 |
158.99 |
953.93 |
|
НСР-7189/09.10.2015. |
24.10.2015 |
24.10.2015 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
194.45 |
38.89 |
233.34 |
4% |
7.78 |
202.23 |
40.45 |
242.68 |
16% |
25 |
227.23 |
45.45 |
272.68 |
|
НСР-7187/09.10.2015. |
24.10.2015 |
24.10.2015 |
Неактивен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
379.63 |
75.93 |
455.56 |
4% |
10 |
389.63 |
77.93 |
467.56 |
16% |
25 |
414.63 |
82.93 |
497.56 |
|
НСР-7188/09.10.2015. |
24.10.2015 |
24.10.2015 |
Неактивен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
790.55 |
158.11 |
948.66 |
4% |
10 |
800.55 |
160.11 |
960.66 |
16% |
25 |
825.55 |
165.11 |
990.66 |
|
НСР-155/18.06.2013 |
15.08.2013 |
15.08.2013 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
197.64 |
39.53 |
237.17 |
4% |
7.91 |
205.55 |
41.11 |
246.66 |
16% |
25 |
230.55 |
46.11 |
276.66 |
|
НСР-154/18.06.2013 |
15.08.2013 |
15.08.2013 |
Неактивен |
2006 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
395.27 |
79.05 |
474.32 |
4% |
10 |
405.27 |
81.05 |
486.32 |
16% |
25 |
430.27 |
86.05 |
516.32 |
|
НСР-212/20.06.2013 |
15.08.2013 |
15.08.2013 |
Неактивен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/001 |
Privigen, Solution for infusion, 100 mg/ml - 50 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
399.97 |
79.99 |
479.96 |
4% |
10 |
409.97 |
81.99 |
491.96 |
16% |
25 |
434.97 |
86.99 |
521.96 |
|
КЦ-2567/15.08.2011 |
30.08.2011 |
30.08.2011 |
Неактивен |
2007 |
| Immunoglobulins, normal human |
EU/1/08/446/002 |
Privigen, Solution for infusion, 100 mg/ml - 100 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH, Германия |
799.93 |
159.99 |
959.92 |
4% |
10 |
809.93 |
161.99 |
971.92 |
16% |
25 |
834.93 |
166.99 |
1001.92 |
|
КЦ-2575/15.08.2011 |
30.08.2011 |
30.08.2011 |
Неактивен |
2008 |
| Immunoglobulins, normal human |
EU/1/08/446/004 |
Privigen, Solution for infusion, 100 mg/ml - 25 ml, mg, Pack: 1 |
CSL Behring GmbH, Германия |
CSL Behring GmbH Германия |
199.98 |
40 |
239.98 |
4% |
8 |
207.98 |
41.6 |
249.58 |
16% |
25 |
232.98 |
46.6 |
279.58 |
|
КЦ-2482/26.07.2011 |
09.08.2011 |
09.08.2011 |
Неактивен |
2006 |
| Omeprazole |
20100346 |
Probitor, Powder for solution for infusion, 40, mg, Pack: 10 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
37.69 |
7.54 |
45.23 |
4% |
1.51 |
39.2 |
7.84 |
47.04 |
16% |
6.03 |
45.23 |
9.05 |
54.28 |
Протокол № 236/03.08.2017; Промяна на обстоятелства НСР-14758/22.12.2017 |
НСР-6834/30.07.2015. |
14.08.2015 |
02.02.2018 |
Активен |
1862 |
| Omeprazole |
II-9755/2.6.2010 |
Probitor, Powder for solution for infusion, 40, mg, Pack: 10 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
37.69 |
7.54 |
45.23 |
4% |
1.51 |
39.2 |
7.84 |
47.04 |
16% |
6.03 |
45.23 |
9.05 |
54.28 |
Протокол № 236/03.08.2017 |
НСР-6834/30.07.2015. |
14.08.2015 |
02.09.2017 |
Неактивен |
1862 |
| Omeprazole |
II-9755/2.6.2010 |
Probitor, Powder for concentrate for solution for infusion, 40, mg, Pack: 10 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
37.69 |
7.54 |
45.23 |
4% |
1.51 |
39.2 |
7.84 |
47.04 |
16% |
6.03 |
45.23 |
9.05 |
54.28 |
|
НСР-6834/30.07.2015. |
14.08.2015 |
14.08.2015 |
Неактивен |
1862 |
| Omeprazole |
II-9755/2.6.2010 |
Probitor, Powder for concentrate for solution for infusion, 40, mg, Pack: 10 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
37.88 |
7.58 |
45.46 |
4% |
1.52 |
39.4 |
7.88 |
47.28 |
16% |
6.06 |
45.46 |
9.09 |
54.55 |
|
НСР-57/07.06.2013 |
26.06.2013 |
26.06.2013 |
Неактивен |
1862 |
| Omeprazole |
II-9755/2.6.2010 |
Probitor, Powder for concentrate for solution for infusion, 40, mg, Pack: 10 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
39.55 |
7.91 |
47.46 |
4% |
1.58 |
41.13 |
8.23 |
49.36 |
16% |
6.33 |
47.46 |
9.49 |
56.95 |
|
КЦ-2507/04.08.2011 |
19.08.2011 |
19.08.2011 |
Неактивен |
1862 |
| Ketoprofen |
II-4666/10,04,2009 |
Profenid 100 mg I.V., Powder for solution for infusion, 100, mg, Pack: 50 |
Санофи България ЕООД, България |
Sanofi-Aventis S.P.A., Anagni, Италия; Sanofi Winthrop Industrie, Maisons-Alfort, Франция |
132.78 |
26.56 |
159.34 |
4% |
5.31 |
138.09 |
27.62 |
165.71 |
16% |
21.24 |
159.33 |
31.87 |
191.2 |
промяна на обстоятелства КЦ-999/25.06.2009 г; НСР-4041/03.07.2014; промяна на обстоятелства НСР-13999/25.09.2017 |
КЦ-470/29.01.2009; НСР-14896/25.01.2018 |
09.02.2018 |
02.03.2018 |
Активен |
463 |
| Ketoprofen |
II-4666/10,04,2009 |
Profenid 100 mg I.V., Powder for solution for infusion, 100, mg, Pack: 50 |
Санофи България ЕООД, България |
Sanofi-Aventis S.P.A., Anagni, Италия; Sanofi Winthrop Industrie, Maisons-Alfort, Франция |
120.71 |
24.14 |
144.85 |
4% |
4.83 |
125.54 |
25.11 |
150.65 |
16% |
19.31 |
144.85 |
28.97 |
173.82 |
промяна на обстоятелства КЦ-999/25.06.2009 г; НСР-4041/03.07.2014; промяна на обстоятелства НСР-13999/25.09.2017 |
КЦ-470/29.01.2009 |
12.02.2009 |
02.11.2017 |
Неактивен |
463 |
| Ketoprofen |
II-4666/10,04,2009 |
Profenid 100 mg I.V., Powder for solution for infusion, 100, mg, Pack: 50 |
Санофи-Авентис България ЕООД, България |
Sanofi-Aventis S.P.A., Anagni, Италия; Sanofi Winthrop Industrie, Maisons-Alfort, Франция |
120.71 |
24.14 |
144.85 |
4% |
4.83 |
125.54 |
25.11 |
150.65 |
16% |
19.31 |
144.85 |
28.97 |
173.82 |
промяна на обстоятелства КЦ-999/25.06.2009 г; НСР-4041/03.07.2014 |
КЦ-470/29.01.2009 |
12.02.2009 |
12.02.2009 |
Неактивен |
463 |
| Propofol |
20060028 |
Profol, Emulsion for infusion, 10 mg/ml - 20 ml, -, Pack: 5 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД, България |
39.51 |
7.9 |
47.41 |
4% |
1.58 |
41.09 |
8.22 |
49.31 |
16% |
6.32 |
47.41 |
9.48 |
56.89 |
Протокол № 251/16.11.2017 |
НСР-7116/24.09.2015; НСР-16219/19.07.2018 |
10.10.2015 |
02.09.2018 |
Заличен |
4077 |
| Propofol |
20060028 |
Profol, Emulsion for infusion, 10 mg/ml - 20 ml, -, Pack: 5 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД, България |
39.51 |
7.9 |
47.41 |
4% |
1.58 |
41.09 |
8.22 |
49.31 |
16% |
6.32 |
47.41 |
9.48 |
56.89 |
Протокол № 251/16.11.2017 |
НСР-7116/24.09.2015 |
10.10.2015 |
02.12.2017 |
Неактивен |
4077 |
| Propofol |
16006/23.02.2007 г. |
PROFOL 1%, Emulsion for infusion, 10 mg/ml - 20 ml, -, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
3.94 |
0.79 |
4.73 |
7% |
0.28 |
4.22 |
0.84 |
5.06 |
20% |
0.79 |
5.01 |
1 |
6.01 |
|
НСР-8565/24.03.2016.; НСР-15882/15.06.2018 |
30.06.2018 |
02.07.2018 |
Активен |
384 |
| Propofol |
16006/23.02.2007 г. |
PROFOL 1%, Emulsion for infusion, 10 mg/ml - 20 ml, -, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
3.97 |
0.79 |
4.76 |
7% |
0.28 |
4.25 |
0.85 |
5.1 |
20% |
0.79 |
5.04 |
1.01 |
6.05 |
|
НСР-8565/24.03.2016. |
08.04.2016 |
08.04.2016 |
Неактивен |
384 |